obesity drug news today glp-1 today drugs Market Overview: GLP-1 Agonists and the Obesity Market The current range of weight-loss
Description
A: Compounded Tirzepatide contains the same active pharmaceutical ingredient as the brand-name product but is custom-made by a licensed US compounding pharmacy
The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease in Liver Transplant Recipients
SGLT2 inhibitors are prescription oral medications used to treat type 2 diabetes, which includes empagliflozin (Jardiance)
By 2017 revenue from liraglutide was US $843 million, and the overall market for GLP-1 drugs was growing 30 percent, up from just 3 percent in 2014 (Staton)
PMC 3687347
